Trials / Completed
CompletedNCT00976053
Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging
Clinical Effectiveness of Pharmacologic Stress Radionuclide Myocardial Perfusion Imaging as a Guide to Management of Patients With Known CAD: Comparison of Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 330 (actual)
- Sponsor
- Aspire Foundation · Academic / Other
- Sex
- All
- Age
- 30 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare pharmacologic stress myocardial perfusion PET with pharmacologic stress myocardial perfusion SPECT in a near-simultaneous, head-to-head comparison in the same patient. The investigators hypothesize that pharmacologic stress myocardial perfusion PET will prove superior to pharmacologic stress myocardial perfusion SPECT as a first-line diagnostic test for higher-risk patients with known coronary artery disease (CAD) who present with symptoms consistent with possible worsening of their CAD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Myocardial perfusion imaging | Randomization assignment to one of SPECT or PET myocardial perfusion imaging |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2013-09-01
- Completion
- 2014-10-01
- First posted
- 2009-09-14
- Last updated
- 2014-10-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00976053. Inclusion in this directory is not an endorsement.